ATAI - ATAI Life Sciences GAAP EPS of -$0.24 misses by $0.01
- ATAI Life Sciences press release ( NASDAQ: ATAI ): Q2 GAAP EPS of -$0.24 misses by $0.01 .
- Cash, cash equivalents and short-term investments totaled $312.5 million as of June 30, 2022, compared to $362.3 million as of December 31, 2021.
For further details see:
ATAI Life Sciences GAAP EPS of -$0.24 misses by $0.01